Pharmaceutical Technology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
The Pharmaceutical Technology Section is devoted to the description of tools enabling the modulation of interactions between drugs or drug candidates and their specific targets. It concerns all technologies and methods related to the development of a pharmaceutical form using natural, semi-synthetic, and synthetic active and auxiliary substances, production in industry, and use in patients. This includes:
- Drug chemistry
- Process technology
- Innovative instrumentation
- Drug manufacturing
- Drug analysis
- Drug production
- Drug delivery
- Management and analysis of data
- Test and quality control
- Regulatory affairs
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Bacteriophages as Therapeutic Delivery Vehicles (Deadline: 31 January 2021)
- Nano Drug Carriers 2021 (Deadline: 15 February 2021)
- Biomedical Applications of Fluorescent Gold Nanotechnologies (Deadline: 28 February 2021)
- Nanoparticle-Mediated Drug Delivery, Imaging, and Control of Cellular Functions (Deadline: 5 March 2021)
- Applications of Micro-Nanosystems in Retinoids Delivery (Deadline: 15 March 2021)
- Protein-Based Biomaterial for Pharmaceutical and Biomedical Applications (Deadline: 30 March 2021)
- Photodynamic Therapy 2021 (Deadline: 31 March 2021)
- Formulations for Wound Healing (Deadline: 1 April 2021)
- Therapeutic Drug Monitoring and Drug-Drug Interactions (Deadline: 1 April 2021)
- Analytical Techniques in the Pharmaceutical Sciences (Deadline: 15 April 2021)
- Advances in 3D Printed Drug Controlled Delivery Systems and Biomedical Applications (Deadline: 26 April 2021)
- Medication Safety in Patients with Liver Disease (Deadline: 30 April 2021)
- Impacts of Constituent Material Variability on the Performance and Quality of Pharmaceutical Dosage Forms (Deadline: 30 April 2021)
- Development of Colon Targeted Drug Delivery System (Deadline: 14 June 2021)
- Multi-Component Delivery Systems for Targeted Delivery of Nucleic Acids (Deadline: 18 June 2021)
- Targeted and Stimulus-Responsive Nanomedicines for the Treatment of Central Nervous System (CNS) Disorders (Deadline: 30 June 2021)
- Emerging Platforms in Nanotechnology for Diagnosis and Treatment of Respiratory and Infectious Diseases (Deadline: 1 November 2021)
